Wells Fargo’s Enanta Pharmaceuticals ENTA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $187K | Buy |
|
|||||
|
2025
Q2 | $114K | Buy |
|
|||||
|
2025
Q1 | $78.4K | Sell |
|
|||||
|
2024
Q4 | $91.3K | Buy |
|
|||||
|
2024
Q3 | $97K | Buy |
|
|||||
|
2024
Q2 | $116K | Sell |
|
|||||
|
2024
Q1 | $435K | Buy |
|
|||||
|
2023
Q4 | $58.1K | Buy |
|
|||||
|
2023
Q3 | $55.6K | Sell |
|
|||||
|
2023
Q2 | $524K | Buy |
|
|||||
|
2023
Q1 | $564K | Buy |
|
|||||
|
2022
Q4 | $38K | Sell |
|
|||||
|
2022
Q3 | $96K | Sell |
|
|||||
|
2022
Q2 | $98K | Sell |
|
|||||
|
2022
Q1 | $1.19M | Sell |
|
|||||
|
2021
Q4 | $1.67M | Buy |
|
|||||
|
2021
Q3 | $881K | Sell |
|
|||||
|
2021
Q2 | $910K | Buy |
|
|||||
|
2021
Q1 | $207K | Sell |
|
|||||
|
2020
Q4 | $1.78M | Buy |
|
|||||
|
2020
Q3 | $1.86M | Sell |
|
|||||
|
2020
Q2 | $2.08M | Buy |
|
|||||
|
2020
Q1 | $1.77M | Buy |
|
|||||
|
2019
Q4 | $1.98M | Buy |
|
|||||
|
2019
Q3 | $1.8M | Buy |
|
|||||
|
2019
Q2 | $2.43M | Buy |
|
|||||
|
2019
Q1 | $2.6M | Sell |
|
|||||
|
2018
Q4 | $1.95M | Buy |
|
|||||
|
2018
Q3 | $2.06M | Sell |
|
|||||
|
2018
Q2 | $4.96M | Buy |
|
|||||
|
2018
Q1 | $2.05M | Buy |
|
|||||
|
2017
Q4 | $1.37M | Buy |
|
|||||
|
2017
Q3 | $852K | Buy |
|
|||||
|
2017
Q2 | $479K | Sell |
|
|||||
|
2017
Q1 | $660K | Buy |
|
|||||
|
2016
Q4 | $393K | Buy |
|
|||||
|
2016
Q3 | $172K | Sell |
|
|||||
|
2016
Q2 | $1.77M | Sell |
|
|||||
|
2016
Q1 | $2.38M | Sell |
|
|||||
|
2015
Q4 | $2.96M | Buy |
|
|||||
|
2015
Q3 | $1.33M | Buy |
|
|||||
|
2015
Q2 | $1.58M | Buy |
|
|||||
|
2015
Q1 | $1.05M | Sell |
|
|||||
|
2014
Q4 | $2.58M | Buy |
|
|||||
|
2014
Q3 | $1.03M | Sell |
|
|||||
|
2014
Q2 | $1.15M | Sell |
|
|||||
|
2014
Q1 | $2.16M | Buy |
|
|||||
|
2013
Q4 | $857K | Buy |
|
|||||
|
2013
Q3 | $398K | Buy |
|